Executive Vice President, Americas
Plano, Tx, Us
Based in Sydney, Australia and listed on the Australian Stock Exchange August 2004, SomnoMed Ltd. manufactures and markets the SomnoDent MAS, a uniquely designed Mandibular Advancement Splint for the treatment of snoring and obstructive sleep apnea (OSA). SomnoMed Inc. is a wholly owned subsidiary of SomnoMed Ltd based in Denton, Texas USA.SomnoMed Ltd (ASX:SOM) January 2004- January 2006• Completed market research, coauthored prospectus, developed offering with V.C. group Roslyndale Ltd, contacted institutions, conducted road show and listed company on the ASX August 27, 2004.• Located and designed custom build facility in Crows Nest Australia, developed initial strategy for Asia Pacific region and oversaw all aspects of global sales and marketing for SomnoMed Ltd.• Successfully created an international network of dentists and sleep physicians loyal to the company and willing to choose the SomnoDent above other devices.• March – December 2005 evaluated global markets, determined Americas held the most to offer, devised an entry strategy and relocated to the USA.SomnoMed Inc. January 2006 – July 2010• Relocated from parent company in Sydney Australia to the Dallas Fort Worth Metroplex to establish a presence in Americas.• Successes include development of strategy, creation of business plan, design and construction of facility, hiring and training of all personnel, implementation and management of all operations and reporting of results to the Chairman and BOD.• Created the fastest growing region in the company and the first to achieve profit.• Consistently exceeded sales targets and revenue while keeping costs below budget.• Established Americas as the global leader and “engine room” of SomnoMed, facilitating expansion into other world markets.